PATENT CLAIM ANALYSIS

Application Number: 15752575
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "056000"]

Abstract:
The present invention discloses an ovine enoxaparin sodium, a preparation method therefor, and an application thereof. The ovine enoxaparin sodium is prepared from ovine heparin. Compared with enoxaparin sodium derived from porcine intestinal mucosa heparin, both the chemical structures (disaccharide compositions) and the physiochemical properties are different. Through process of optimization and precipitation, the ovine enoxaparin sodium prepared meets the enoxaparin sodium specifications in the USP 37 and the EP 8.0 as well as specifications in current editions of the USP 39 and the EP 8.6. Also provided are two types of ovine enoxaparin sodium injections, preparation methods therefor, and anticoagulation properties in animal model. The raw material used in the preparation is ovine, which is a Halal material compared to porcine enoxaparin sodium. Therefore, the ovine enoxaparin sodium and the injections thereof are an Halal anticoagulant medicine.

Claim (Index 12):
The method of  claim 9 , wherein in S2, a weight ratio of the benzyl chloride to ovine heparin sodium is 2-5:1.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 2.03947
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13982100', '11805829', '10386402', '13193977', '15735139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703805960185941
- 35 USC 102 Novelty (BERT): 0.5250079121993392
- Combined Prediction Score: 0.7458433276366686
- Mean Citation Score: 234.99371
- Max Citation Score: 305.69705
- Similarity Product: 178.24690903257724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test